-
Current Research
/images/logo-galectin-sm.png)
Galectin Therapeutics, Inc.
Colombia Clean Power and Fuels Inc.
ProUroCare Medical Inc.
/images/logo-galectin-sm.png){kind=logo}
Galectin Therapeutics, Inc.
/images/logo1.png){kind=logo}
Colombia Clean Power
and Fuels Inc.
Planning Coal Upgrading Facilities in Colombia.
Objective, detailed, actionable reports.
Wide industry experience, two decades in operation
Our expertise extends to a broad spectrum of industries, from natural resources to manufacturing, telecom and biotech.
We have provided research coverage on nearly 200 stocks, and we benefit from our principals' experience as private investors in many more small companies.
We provide a quantitative, actionable analysis of a company's operations and finances. Our reports make technical issues accessible, and we are trusted to be forthright about risks.
business get the exposure it needs to grow.
Non-promotional emerging-growth research
for the independent investor.
Institutional-caliber research on under-covered equities
For over two decades, the Research Works has provided non-promotional, actionable research on early stage companies that fly under the radar of larger institutions. Our reports are well-respected in the private placement and banking circles that help small companies achieve their goals, as we are discriminating in our clientel and rigorous in our analysis.
Read more about our services
RW 360 Mining Report
In cooperation with MiningAlmanac.com we have developed special mining reports to help investors evaluate resource stocks.
We examine properties, resource estimates, local geology, political considerations, financing arrangements and management's track record
Our reports feature unique mining-specific value ratios, and we show how companies stack up against their close peers.
RW 360 Pharma Report
Reports specially tailored for the pharma industry offer investors quick and valuable insights.
PhDs among our analysts pay particular attention to the clinical trial process and FDA review.
Evaluations sales potential and the time and expense required to bring products to market.
Peer valuation analysis and discussion of management's experience with product development and fundraising.